Mori, M., Shuto, K., Kosugi, C., Narushima, K., Hayashi, H., Matsubara, H., & Koda, K. (2018). An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer. BMC Cancer.
Chicago Style CitationMori, Mikito, Kiyohiko Shuto, Chihiro Kosugi, Kazuo Narushima, Hideki Hayashi, Hisahiro Matsubara, i Keiji Koda. "An Increase in the Neutrophil-to-lymphocyte Ratio During Adjuvant Chemotherapy Indicates a Poor Prognosis in Patients With Stage II or III Gastric Cancer." BMC Cancer 2018.
Cita MLAMori, Mikito, et al. "An Increase in the Neutrophil-to-lymphocyte Ratio During Adjuvant Chemotherapy Indicates a Poor Prognosis in Patients With Stage II or III Gastric Cancer." BMC Cancer 2018.